Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Stan Berenshteyn is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/18/2024
Buy Now | Get Alert | ||||||||
---|---|---|---|---|---|---|---|---|---|
07/18/2024 | DOCS | Buy Now | Doximity | $27.55 | -31.05% | $27 → $19 | Downgrade | Equal-Weight → Underweight | Get Alert |
06/20/2024 | HQY | Buy Now | HealthEquity | $78.65 | 39.86% | $107 → $110 | Maintains | Overweight | Get Alert |
06/04/2024 | HQY | Buy Now | HealthEquity | $78.65 | 36.05% | $105 → $107 | Maintains | Overweight | Get Alert |
05/10/2024 | HCAT | Buy Now | Health Catalyst | $7.25 | 79.31% | $14 → $13 | Maintains | Overweight | Get Alert |
04/30/2024 | ACCD | Buy Now | Accolade | $3.71 | 169.91% | $12 → $10 | Maintains | Equal-Weight | Get Alert |
03/25/2024 | GDRX | Buy Now | GoodRx Holdings | $8.35 | 19.76% | → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
03/01/2024 | GDRX | Buy Now | GoodRx Holdings | $8.35 | -10.18% | $6 → $7.5 | Maintains | Equal-Weight | Get Alert |
02/09/2024 | OMCL | Buy Now | Omnicell | $28.42 | -8.52% | $28 → $26 | Maintains | Equal-Weight | Get Alert |
02/09/2024 | DOCS | Buy Now | Doximity | $27.55 | -2.01% | $25 → $27 | Maintains | Equal-Weight | Get Alert |
01/09/2024 | ACCD | Buy Now | Accolade | $3.71 | 223.89% | $10 → $12 | Maintains | Equal-Weight | Get Alert |
12/06/2023 | HQY | Buy Now | HealthEquity | $78.65 | 18.25% | $89 → $93 | Maintains | Overweight | Get Alert |
11/03/2023 | OMCL | Buy Now | Omnicell | $28.42 | -1.48% | $39 → $28 | Upgrade | Underweight → Equal-Weight | Get Alert |
10/25/2023 | VEEV | Buy Now | Veeva Sys | $181.93 | 25.87% | $211 → $229 | Upgrade | Equal-Weight → Overweight | Get Alert |
10/11/2023 | ACCD | Buy Now | Accolade | $3.71 | 169.91% | $14 → $10 | Maintains | Equal-Weight | Get Alert |
09/26/2023 | OMCL | Buy Now | Omnicell | $28.42 | 37.23% | $56 → $39 | Maintains | Underweight | Get Alert |
09/05/2023 | VEEV | Buy Now | Veeva Sys | $181.93 | 15.98% | $180 → $211 | Maintains | Equal-Weight | Get Alert |
08/11/2023 | DOCS | Buy Now | Doximity | $27.55 | -9.27% | $37 → $25 | Maintains | Equal-Weight | Get Alert |
08/10/2023 | GDRX | Buy Now | GoodRx Holdings | $8.35 | -16.17% | $6 → $7 | Maintains | Equal-Weight | Get Alert |
07/20/2023 | OMCL | Buy Now | Omnicell | $28.42 | 97.04% | $65 → $56 | Downgrade | Overweight → Underweight | Get Alert |
06/30/2023 | ACCD | Buy Now | Accolade | $3.71 | 277.87% | $13 → $14 | Maintains | Equal-Weight | Get Alert |
05/01/2023 | DOCS | Buy Now | Doximity | $27.55 | 34.28% | $39 → $37 | Downgrade | Overweight → Equal-Weight | Get Alert |
04/21/2023 | ACCD | Buy Now | Accolade | $3.71 | 250.88% | $10 → $13 | Maintains | Equal-Weight | Get Alert |
04/04/2023 | HCAT | Buy Now | Health Catalyst | $7.25 | 120.69% | $13 → $16 | Upgrade | Equal-Weight → Overweight | Get Alert |
03/07/2023 | HCAT | Buy Now | Health Catalyst | $7.25 | 79.31% | $11 → $13 | Maintains | Equal-Weight | Get Alert |
03/06/2023 | TDOC | Buy Now | Teladoc Health | $9.88 | 132.74% | $28 → $23 | Maintains | Equal-Weight | Get Alert |
03/02/2023 | GDRX | Buy Now | GoodRx Holdings | $8.35 | -28.14% | $5.5 → $6 | Maintains | Equal-Weight | Get Alert |
02/10/2023 | DOCS | Buy Now | Doximity | $27.55 | 41.54% | $44 → $39 | Maintains | Overweight | Get Alert |
02/03/2023 | HQY | Buy Now | HealthEquity | $78.65 | 13.16% | $101 → $89 | Maintains | Overweight | Get Alert |
01/24/2023 | OMCL | Buy Now | Omnicell | $28.42 | 128.71% | $71 → $65 | Maintains | Overweight | Get Alert |
12/07/2022 | HQY | Buy Now | HealthEquity | $78.65 | 28.42% | $104 → $101 | Maintains | Overweight | Get Alert |
11/11/2022 | DOCS | Buy Now | Doximity | $27.55 | 59.68% | $38 → $44 | Maintains | Overweight | Get Alert |
11/04/2022 | OMCL | Buy Now | Omnicell | $28.42 | 149.82% | $158 → $71 | Maintains | Overweight | Get Alert |
10/31/2022 | VEEV | Buy Now | Veeva Sys | $181.93 | -1.06% | → $180 | Initiates | → Equal-Weight | Get Alert |
10/31/2022 | HCAT | Buy Now | Health Catalyst | $7.25 | 37.93% | → $10 | Initiates | → Equal-Weight | Get Alert |
10/31/2022 | DOCS | Buy Now | Doximity | $27.55 | 37.91% | → $38 | Initiates | → Overweight | Get Alert |
10/25/2022 | HQY | Buy Now | HealthEquity | $78.65 | 32.23% | $100 → $104 | Maintains | Overweight | Get Alert |
10/12/2022 | ACCD | Buy Now | Accolade | $3.71 | 169.91% | $8 → $10 | Maintains | Equal-Weight | Get Alert |
09/13/2022 | HQY | Buy Now | HealthEquity | $78.65 | 27.15% | $95 → $100 | Maintains | Overweight | Get Alert |
07/05/2022 | ACCD | Buy Now | Accolade | $3.71 | 115.92% | $6 → $8 | Maintains | Equal-Weight | Get Alert |
05/12/2022 | GDRX | Buy Now | GoodRx Holdings | $8.35 | 7.78% | $20 → $9 | Maintains | Equal-Weight | Get Alert |
05/03/2022 | OMCL | Buy Now | Omnicell | $28.42 | 455.95% | $188 → $158 | Maintains | Overweight | Get Alert |
05/02/2022 | ACCD | Buy Now | Accolade | $3.71 | 61.94% | → $6 | Upgrade | Underweight → Equal-Weight | Get Alert |
04/28/2022 | TDOC | Buy Now | Teladoc Health | $9.88 | 304.76% | → $40 | Downgrade | Overweight → Equal-Weight | Get Alert |
04/11/2022 | HQY | Buy Now | HealthEquity | $78.65 | 20.79% | → $95 | Initiates | → Overweight | Get Alert |
04/11/2022 | GDRX | Buy Now | GoodRx Holdings | $8.35 | 139.52% | → $20 | Initiates | → Equal-Weight | Get Alert |
04/11/2022 | ACCD | Buy Now | Accolade | $3.71 | 142.91% | → $9 | Initiates | → Underweight | Get Alert |
02/28/2022 | AMWL | Buy Now | American Well | $8.21 | -51.3% | $120 → $80 | Maintains | Equal-Weight | Get Alert |
02/16/2022 | OMCL | Buy Now | Omnicell | $28.42 | 561.51% | $203 → $188 | Maintains | Overweight | Get Alert |
12/06/2021 | OMCL | Buy Now | Omnicell | $28.42 | 614.29% | — | Initiates | → Overweight | Get Alert |